Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#1 / 55 Total
ACRV - Acrivon Therapeutics Inc - Stock Price Chart
TickerACRV [NASD, RUT]
CompanyAcrivon Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap159.56MEPS (ttm)-2.30
P/E-EPS this Y-10.46%
Forward P/E-EPS next Y-6.87%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B1.16EPS Q/Q-48.75%
Dividend-Sales Q/Q-
Insider Own45.84%Inst Own59.78%
Insider Trans0.00%Inst Trans-
Short Float4.04%EarningsMar 28/b
Analyst Recom1.00Target Price19.33
Avg Volume74.15K52W Range3.19 - 14.39
Today 08:00AM Acrivon Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights (GlobeNewswire) +11.68%
Mar-05-24 04:30PM Acrivon Therapeutics to Present Data at AACR Annual Meeting Demonstrating Power of Acrivon Predictive Precision Proteomics (AP3) Platform and its Internally-Discovered, Potent WEE1/PKMYT1 Development Candidate, ACR-2316 (GlobeNewswire)
Mar-04-24 08:00AM Acrivon Therapeutics Appoints Santhosh Palani, Ph.D., CFA, Experienced Board Member and Healthcare Investor, to its Board of Directors (GlobeNewswire) -11.40%
Feb-27-24 08:00AM Acrivon Therapeutics to Participate in a Panel Discussion at the TD Cowen 44th Annual Health Care Conference (GlobeNewswire) +22.07%
Feb-08-24 08:00AM Acrivon Therapeutics Appoints Seasoned Industry Executive Ivana Magov evi -Liebisch, Ph.D., J.D., to Board of Directors (GlobeNewswire)
Feb-06-24 08:00AM Acrivon Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference (GlobeNewswire)
Jan-12-24 04:00PM Acrivon Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jan-04-24 08:00AM Acrivon Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) -6.63%
Jan-03-24 08:00AM Acrivon Therapeutics Appoints Jean-Marie Cuillerot, M.D., as Chief Medical Officer (GlobeNewswire)
Nov-28-23 08:00AM Acrivon Therapeutics Announces FDA has Granted Breakthrough Device Designation for ACR-368 OncoSignature Assay for Ovarian Cancer (GlobeNewswire)
Acrivon Therapeutics, Inc. develops drugs for clinical treatment. Its unique precision medicine platform is Acrivon Predictive Precision Proteomics (AP3). AP3 is used to generate proprietary OncoSignature companion diagnostics to identify patients who will benefit from the medicine. The company was founded by Peter Blume-Jensen and Kristina Masson in 2018 and is headquartered in Watertown, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Chione Ltd10% OwnerJun 26 '23Sale12.93162073,848,632Jun 28 03:47 PM
Holm-Jorgensen RasmusChief Financial OfficerJun 16 '23Option Exercise3.639,50034,48529,530Jun 20 05:21 PM
Chione Ltd10% OwnerJun 15 '23Sale12.142,05624,9603,848,648Jun 20 05:15 PM
Chione Ltd10% OwnerJun 14 '23Sale12.1389310,8323,850,704Jun 14 06:33 PM
Chione Ltd10% OwnerJun 13 '23Sale12.303,00036,9003,851,597Jun 14 06:33 PM
AFMD - Affimed N.V. - Stock Price Chart
TickerAFMD [NASD]
CompanyAffimed N.V.
CountryGermany
IndustryBiotechnology
Market Cap80.77MEPS (ttm)-0.85
P/E-EPS this Y-21.36%
Forward P/E-EPS next Y43.21%
PEG-EPS past 5Y4.02%
P/S4.06EPS next 5Y-
P/B9.99EPS Q/Q-59.53%
Dividend-Sales Q/Q-85.76%
Insider Own13.11%Inst Own27.50%
Insider Trans0.00%Inst Trans-
Short Float1.32%EarningsMar 28/b
Analyst Recom1.00Target Price4.50
Avg Volume95.34K52W Range2.23 - 11.10
Affimed NV engages in the discovery and development of cancer immunotherapies. It is a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer by actualizing the untapped potential of the innate immune system. The company's proprietary ROCK platform enables a tumor-targeted approach to recognize and kill a range of hematologic and solid tumors, enabling a broad pipeline of wholly-owned and partnered single agent and combination therapy programs. The ROCK platform predictably generates customized innate cell engager molecules, which use patient's immune cells to destroy tumor cells. The company was founded in 2000 and is headquartered in Heidelberg, Germany.
AGRX - Agile Therapeutics Inc - Stock Price Chart
TickerAGRX [NASD]
CompanyAgile Therapeutics Inc
CountryUSA
IndustryDrug Manufacturers - Specialty & Generic
Market Cap0.97MEPS (ttm)-13.10
P/E-EPS this Y93.57%
Forward P/E-EPS next Y89.86%
PEG-EPS past 5Y49.72%
P/S0.05EPS next 5Y-
P/B-EPS Q/Q98.98%
Dividend-Sales Q/Q121.92%
Insider Own3.90%Inst Own8.53%
Insider Trans0.00%Inst Trans-
Short Float7.79%EarningsMar 28/b
Analyst Recom3.00Target Price5.00
Avg Volume734.85K52W Range0.20 - 12.25
Agile Therapeutics, Inc. is a healthcare company, which engages in the development and commercialization of transdermal patches. Its lead product candidate, Twirla, also known as AG200-15, is an investigational low-dose, non-daily prescription contraceptive. The company was founded by Chien Te Yen on December 22, 1997 and is headquartered in Princeton, NJ.
AONC - American Oncology Network Inc - Stock Price Chart
TickerAONC [NASD]
CompanyAmerican Oncology Network Inc
CountryUSA
IndustryMedical Care Facilities
Market Cap52.53MEPS (ttm)-0.03
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B6.59EPS Q/Q-476.06%
Dividend-Sales Q/Q-
Insider Own73.62%Inst Own1.80%
Insider Trans0.00%Inst Trans10.68%
Short Float0.81%EarningsMar 28/b
Analyst Recom-Target Price-
Avg Volume9.56K52W Range4.78 - 39.60
American Oncology Network, Inc. engages in the provision of community-based oncology management. The company was founded on November 17, 2020 and is headquartered in Fort Myers, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Saba Capital Management, L.P.10% OwnerSep 25 '23Sale10.50205,5122,157,8760Sep 25 05:59 PM
APLM - Apollomics Inc - Stock Price Chart
TickerAPLM [NASD]
CompanyApollomics Inc
CountryUSA
IndustryBiotechnology
Market Cap53.72MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B0.07EPS Q/Q-1366.67%
Dividend-Sales Q/Q-
Insider Own27.31%Inst Own0.31%
Insider Trans0.00%Inst Trans-
Short Float0.07%EarningsMar 28/b
Analyst Recom1.00Target Price17.00
Avg Volume234.52K52W Range0.52 - 49.00
Apollomics, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of oncology therapies to address unmet medical needs. The company was founded by Liang Yu Guo and Sanjeev Redkar in 2015 and is headquartered in Foster City, CA.
ATAT - Atour Lifestyle Holdings Ltd ADR - Stock Price Chart
TickerATAT [NASD]
CompanyAtour Lifestyle Holdings Ltd ADR
CountryChina
IndustryLodging
Market Cap1.90BEPS (ttm)0.43
P/E40.99EPS this Y2018.56%
Forward P/E16.10EPS next Y45.02%
PEG1.84EPS past 5Y-
P/S3.54EPS next 5Y22.22%
P/B9.45EPS Q/Q100.85%
Dividend0.46%Sales Q/Q82.63%
Insider Own3.33%Inst Own20.62%
Insider Trans0.00%Inst Trans-
Short Float0.34%EarningsMar 28/b
Analyst Recom1.00Target Price29.60
Avg Volume521.32K52W Range14.80 - 27.50
Atour Lifestyle Holdings Ltd. engages in the development of lifestyle brands around hotel. The company was founded by Hai Jun Wang on April 10, 2012 and is headquartered in Shanghai, China.
ATRA - Atara Biotherapeutics Inc - Stock Price Chart
TickerATRA [NASD, RUT]
CompanyAtara Biotherapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap91.16MEPS (ttm)-2.77
P/E-EPS this Y57.32%
Forward P/E-EPS next Y22.59%
PEG-EPS past 5Y10.97%
P/S20.08EPS next 5Y-
P/B-EPS Q/Q20.10%
Dividend-Sales Q/Q-52.05%
Insider Own7.14%Inst Own56.27%
Insider Trans8.24%Inst Trans-0.33%
Short Float9.19%EarningsMar 28/b
Analyst Recom2.60Target Price4.83
Avg Volume3.19M52W Range0.20 - 3.08
Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company, which engages in the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases. It also delivers off-the-shelf treatments to patients with high unmet medical need. Its product pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in Thousand Oaks, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Touchon PascalPresident and CEOMar 04 '24Sale0.7224,84417,8881,910,652Mar 06 06:19 PM
Nguyen AnhCoEVP, Chief Sci. & Tech OfficerMar 04 '24Sale0.7210,7467,737941,397Mar 06 06:18 PM
Murugan AmarEVP, Chief Legal OfficerMar 04 '24Sale0.7210,0447,232727,521Mar 06 06:18 PM
Henrich JillEVP, Global Head RA & QualityMar 04 '24Sale0.723,8792,793555,001Mar 06 06:16 PM
Touchon PascalPresident and CEONov 16 '23Sale0.3920,4097,939655,496Nov 20 05:31 PM
AZUL - Azul S.A. ADR - Stock Price Chart
TickerAZUL [NYSE]
CompanyAzul S.A. ADR
CountryBrazil
IndustryAirlines
Market Cap892.88MEPS (ttm)-2.22
P/E-EPS this Y66.09%
Forward P/E10.44EPS next Y178.09%
PEG-EPS past 5Y-
P/S0.25EPS next 5Y-
P/B-EPS Q/Q13.94%
Dividend-Sales Q/Q20.68%
Insider Own-Inst Own21.72%
Insider Trans-Inst Trans-0.94%
Short Float3.12%EarningsMar 28/b
Analyst Recom1.92Target Price14.54
Avg Volume1.25M52W Range5.80 - 13.86
Azul SA is a holding company, which engages in the provision of airline passenger and cargo services. The firm's service features include passenger seat selection, leather seats, individual entertainment screens with free live television at every seat in all E-Jets, extensive legroom with a pitch of 30 inches or more, complimentary beverage and snack services and free bus service to key airports. The company was founded by David Neeleman on January 03, 2008 and is headquartered in Barueri, Brazil.
BETR - Better Home & Finance Holding Co. - Stock Price Chart
TickerBETR [NASD]
CompanyBetter Home & Finance Holding Co.
CountryUSA
IndustryMortgage Finance
Market Cap391.06MEPS (ttm)-0.49
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S23.77EPS next 5Y-
P/B2.29EPS Q/Q-2363.31%
Dividend-Sales Q/Q-
Insider Own69.89%Inst Own11.49%
Insider Trans0.00%Inst Trans0.26%
Short Float2.38%EarningsMar 28/b
Analyst Recom-Target Price-
Avg Volume1.31M52W Range0.34 - 62.91
Better Home & Finance Holding Co. engages in the provision of comprehensive homeownership services. It offers mortgage loans, real estate agent services, and title and homeowner's insurance services. The company is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Tuffin PaulaGeneral Counsel and CCOFeb 01 '24Option Exercise0.00129,6000129,600Feb 05 05:52 PM
RYAN KEVIN JChief Financial OfficerFeb 01 '24Option Exercise0.003,088,00003,088,000Feb 06 05:07 PM
BOSC - B.O.S. Better Online Solutions - Stock Price Chart
TickerBOSC [NASD]
CompanyB.O.S. Better Online Solutions
CountryIsrael
IndustryCommunication Equipment
Market Cap17.14MEPS (ttm)0.36
P/E8.20EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-0.86%
P/S0.38EPS next 5Y-
P/B0.93EPS Q/Q7.53%
Dividend-Sales Q/Q8.51%
Insider Own15.98%Inst Own16.05%
Insider Trans0.00%Inst Trans-2.27%
Short Float0.54%EarningsMar 28/b
Analyst Recom-Target Price-
Avg Volume10.21K52W Range2.32 - 4.16
BOS Better Online Solutions Ltd. provides intelligent robotics and supply chain solutions to enterprises. It offers smart automation systems for industrial processes, logistics and retail stores. The firm operates through the following segments: Intelligent Robotics, Radio Frequency Identification (RFID), and Supply Chain Solutions. The company was founded by Israel Gal in 1990 and is headquartered in Rishon LeZion, Israel.
123456